BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17326278)

  • 1. Voriconazole: serious adverse effects and interactions.
    Prescrire Int; 2007 Feb; 16(87):18. PubMed ID: 17326278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse effects of voriconazole: analysis of the French Pharmacovigilance Database.
    Eiden C; Peyrière H; Cociglio M; Djezzar S; Hansel S; Blayac JP; Hillaire-Buys D;
    Ann Pharmacother; 2007 May; 41(5):755-63. PubMed ID: 17456542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voriconazole inhibition of vitamin A metabolism: are adverse events increased in cystic fibrosis patients?
    Cheng MP; Paquette K; Lands LC; Ovetchkine P; Théoret Y; Quach C
    Pediatr Pulmonol; 2010 Jul; 45(7):661-6. PubMed ID: 20575095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Complex visual hallucinations induced by voriconazole].
    Fernández-Ruiz M; López-Medrano F; Gutiérrez E; Aguado JM
    Med Clin (Barc); 2009 Jun; 133(4):156-7. PubMed ID: 19540418
    [No Abstract]   [Full Text] [Related]  

  • 5. Investigation of the potential relationships between plasma voriconazole concentrations and visual adverse events or liver function test abnormalities.
    Tan K; Brayshaw N; Tomaszewski K; Troke P; Wood N
    J Clin Pharmacol; 2006 Feb; 46(2):235-43. PubMed ID: 16432276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of cross-hepatotoxicity between voriconazole and posaconazole.
    Foo H; Gottlieb T
    Clin Infect Dis; 2007 Sep; 45(6):803-5. PubMed ID: 17712772
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical application of voriconazole concentrations in the treatment of invasive aspergillosis.
    Howard A; Hoffman J; Sheth A
    Ann Pharmacother; 2008 Dec; 42(12):1859-64. PubMed ID: 19017830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Voriconazole safety: short review of clinical data].
    Veselov AV; Belousov DIu
    Antibiot Khimioter; 2006; 51(3-4):19-25. PubMed ID: 17165257
    [No Abstract]   [Full Text] [Related]  

  • 9. Persistent photopsia following course of oral voriconazole.
    Kadikoy H; Barkmeier A; Peck B; Carvounis PE
    J Ocul Pharmacol Ther; 2010 Aug; 26(4):387-8. PubMed ID: 20653481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse effects of voriconazole.
    Lohr L
    Orthopedics; 2004 May; 27(5):472-3. PubMed ID: 15181941
    [No Abstract]   [Full Text] [Related]  

  • 11. Neurological adverse events to voriconazole: evidence for therapeutic drug monitoring.
    Imhof A; Schaer DJ; Schanz U; Schwarz U
    Swiss Med Wkly; 2006 Nov; 136(45-46):739-42. PubMed ID: 17183438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voriconazole: new preparation. Invasive aspergillosis: benefits to be confirmed.
    Prescrire Int; 2004 Feb; 13(69):13-6. PubMed ID: 15055210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hallucinations during voriconazole therapy: who is at higher risk and could benefit from therapeutic drug monitoring?
    Pea F; Viale P
    Ther Drug Monit; 2009 Feb; 31(1):135-6. PubMed ID: 19077926
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hallucinosis as side effect of voriconazole].
    Flox Benítez G; Rondón Fernández P; Quero Escalada M; Fernández Ballesteros A
    Rev Clin Esp; 2005 Dec; 205(12):632-3. PubMed ID: 16527191
    [No Abstract]   [Full Text] [Related]  

  • 15. Adverse reactions to voriconazole.
    Boyd AE; Modi S; Howard SJ; Moore CB; Keevil BG; Denning DW
    Clin Infect Dis; 2004 Oct; 39(8):1241-4. PubMed ID: 15486850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voriconazole-induced photosensitivity.
    Malani AN; Aronoff DM
    Clin Med Res; 2008 Sep; 6(2):83-5. PubMed ID: 18801950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.
    Walsh TJ; Pappas P; Winston DJ; Lazarus HM; Petersen F; Raffalli J; Yanovich S; Stiff P; Greenberg R; Donowitz G; Schuster M; Reboli A; Wingard J; Arndt C; Reinhardt J; Hadley S; Finberg R; Laverdière M; Perfect J; Garber G; Fioritoni G; Anaissie E; Lee J;
    N Engl J Med; 2002 Jan; 346(4):225-34. PubMed ID: 11807146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phototoxicity and photocarcinogenesis associated with voriconazole.
    Epaulard O; Leccia MT; Blanche S; Chosidow O; Mamzer-Bruneel MF; Ravaud P; Thiebaut A; Villier C; Lortholary O
    Med Mal Infect; 2011 Dec; 41(12):639-45. PubMed ID: 22055586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe phototoxicity associated with long-term voriconazole treatment.
    Vöhringer S; Schrum J; Ott H; Höger PH
    J Dtsch Dermatol Ges; 2011 Apr; 9(4):274-6. PubMed ID: 21050383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatal dysrhythmia following initiation of lansoprazole during a long-term course of voriconazole.
    Tsubokura M; Miura Y; Itokawa T; Murata K; Takei N; Higaki T; Murashige N; Kami M; Komatsu T
    J Clin Pharmacol; 2011 Oct; 51(10):1488-90. PubMed ID: 21098688
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.